Marked Direct Hyperbilirubinemia due to Ceftriaxone in an Adult with Sickle Cell Disease

Table 1

Serologic evaluation of elevated direct hyperbilirubinemia.

Serological evaluation of direct hyperbilirubinemia	Patient’s value	Normal value
Serum copper level	243	72–166 mcg/dL
Ceruloplasmin	59	15–30 mg/dL
Ferritin	1,850	30–400 ng/mL
Iron	81	59–159 mcg/dL
Total Iron Binding Capacity (TIBC)	207	228–428 mcg/dL
Unsaturated Iron Binding Capacity (UIBC)	126	112–346 mcg/dL
Iron saturation	39	20–55%
Folate	9.6	3.1–17.5 ng/mL
Vitamin B12	697	211–946 pg/mL
Serum zinc	130	60–130 mcg/dL
Hepatitis A total	Negative	Negative
Hepatitis B core antibody IgM	Negative	Negative
Hepatitis B surface antibody	Negative	0.0–9.9 Iunits/mL
Hepatitis B surface antigen	Negative	Negative
Hepatitis C antibody	Negative	Negative
Total IgG	1480	700–1600 mg/dL
Total IgA	376	70–400 mg/dL
Total IgM	19	40–230 mg/dL
Antinuclear Antibody (ANA)	Negative	Negative
Mitochondrial antibody	Nondetected	Nondetected
Smooth muscle antibody	Nondetected	Nondetected